Trial Profile
Effect of mirabegron treatment to reduce the urinary levels of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) in patients with overactive bladder (OAB)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Aug 2015
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Pharmacodynamics
- 18 Aug 2015 New trial record